• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名艾滋病患者中由干扰素诱发的眼部假性肌无力反应。

Ocular pseudo-myasthenic reaction induced by interferon in an AIDS patient.

作者信息

Riedel R R, Schmitt A, Hartmann A

机构信息

Abteilung für Neurologie, Universitätsklinik Bonn.

出版信息

Klin Wochenschr. 1991 Dec 11;69(20):930-1. doi: 10.1007/BF01798543.

DOI:10.1007/BF01798543
PMID:1795499
Abstract

A 32-year-old, HIV-positive homosexual with Kaposi's sarcoma was given subcutaneous interferon-A (IFN) for two- and a-half months. The patient complained of ocular symptoms (ptosis of the left eyelid and intermittent diplopia) after the application of IFN-A. These symptoms persisted for the period of treatment and subsided after therapy was stopped. However after IFN-A was resumed, ptosis and diplopia recurred. Intensive serological and neurological diagnostic investigations failed to present any reason for these ocular symptoms. From data and the clinical appearance we suppose that in this case the patient suffered a pseudo-myasthenic reaction to IFN-A.

摘要

一名32岁、患有卡波西肉瘤的HIV阳性同性恋者接受了两个半月的皮下注射干扰素-A(IFN)治疗。患者在应用干扰素-A后出现眼部症状(左眼睑下垂和间歇性复视)。这些症状在治疗期间持续存在,停药后消退。然而,在重新使用干扰素-A后,上睑下垂和复视再次出现。全面的血清学和神经学诊断检查未能找出这些眼部症状的任何原因。根据数据和临床表现,我们推测该患者在这种情况下对干扰素-A发生了假重症肌无力反应。

相似文献

1
Ocular pseudo-myasthenic reaction induced by interferon in an AIDS patient.一名艾滋病患者中由干扰素诱发的眼部假性肌无力反应。
Klin Wochenschr. 1991 Dec 11;69(20):930-1. doi: 10.1007/BF01798543.
2
Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma.
Lancet. 1988 Nov 26;2(8622):1218-22. doi: 10.1016/s0140-6736(88)90811-2.
3
Ocular myasthenia and nitrofurantoin.眼肌型重症肌无力与呋喃妥因
Am J Ophthalmol. 2000 Oct;130(4):531-3. doi: 10.1016/s0002-9394(00)00556-0.
4
Low-dose interferon alpha combined with zidovudine in patients with AIDS-associated Kaposi's sarcoma.
J Intern Med. 1993 Mar;233(3):247-53. doi: 10.1111/j.1365-2796.1993.tb00983.x.
5
Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma.大剂量重组干扰素-α治疗播散性艾滋病相关卡波西肉瘤的临床及病毒学疗效
Lancet. 1988 Nov 26;2(8622):1214-7. doi: 10.1016/s0140-6736(88)90810-0.
6
D-penicillamine and the ocular myasthenic syndrome.D-青霉胺与眼肌型重症肌无力综合征
Ann Ophthalmol. 1981 Oct;13(10):1171-2.
7
Interferon-alpha therapy in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome.α干扰素治疗卡波西肉瘤和获得性免疫缺陷综合征患者。
Int J Immunopharmacol. 1991;13 Suppl 1:77-81. doi: 10.1016/0192-0561(91)90128-t.
8
Cutaneous local necrosis following interferon injections.
Int J Dermatol. 1991 Feb;30(2):147. doi: 10.1111/j.1365-4362.1991.tb04230.x.
9
Interferon administered intralesionally in skin and oral cavity lesions in heterosexual drug addicted patients with AIDS-related Kaposi's sarcoma.
Eur J Cancer Clin Oncol. 1989 Apr;25(4):759-61. doi: 10.1016/0277-5379(89)90217-4.
10
Ocular myasthenia gravis after D-penicillamine administration.服用青霉胺后发生的眼肌型重症肌无力。
Br J Ophthalmol. 1989 Dec;73(12):1015-8. doi: 10.1136/bjo.73.12.1015.

引用本文的文献

1
Myasthenia gravis developing in an HIV-negative patient with Kaposi's sarcoma.HIV 阴性的卡波西肉瘤患者发生重症肌无力。
Neurol Sci. 2013 Jul;34(7):1249-50. doi: 10.1007/s10072-012-1201-z. Epub 2012 Sep 26.
2
Myasthenia gravis in a patient with chronic active hepatitis C during interferon-alpha treatment.一名慢性丙型肝炎患者在接受α干扰素治疗期间发生重症肌无力。
J Neurol Neurosurg Psychiatry. 1996 Mar;60(3):348. doi: 10.1136/jnnp.60.3.348.

本文引用的文献

1
Neurotoxicity of interferon.干扰素的神经毒性
Cancer Treat Rep. 1983 Oct;67(10):958-61.
2
Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients.重组干扰素α-2a(罗扰素)在癌症患者中的安全性和耐受性。
Cancer. 1986 Apr 15;57(8 Suppl):1709-15. doi: 10.1002/1097-0142(19860415)57:8+<1709::aid-cncr2820571315>3.0.co;2-f.
3
Central nervous system toxicity of interferons and other cytokines.
J Biol Regul Homeost Agents. 1988 Jul-Sep;2(3):107-18.
4
Interferons.
Lancet. 1989 May 13;1(8646):1060-3. doi: 10.1016/s0140-6736(89)92455-0.